Safety of CDKI combined with radiotherapy in hormone receptor positive breast cancer

被引：0
|
作者：
Falivene, S. [1 ]
Scipilliti, E. [2 ]
Ferraioli, P. [2 ]
Ravo, V. [2 ]
Muto, P. [2 ]
机构：
[1] INT IRCCS Fdn Pascale, Rdiotherapy, Naples, Italy
[2] INT IRCCS Fdn Pascale, Radiotherapy, Naples, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1247
引用
收藏
页码：S998 / S998
页数：1
相关论文
共 50 条
  • [41] The role of chemotherapy in hormone receptor positive advanced breast cancer
    Barrios Carlos, H.
    GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (05): : 215 - 221
  • [42] Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping
    Xiangcheng Zhi
    Xiaonan Yang
    Teng Pan
    Jingjing Liu
    Xiao Chen
    Liping Lou
    Zhendong Shi
    Jin Zhang
    Chinese Journal of Cancer Research, 2019, 31 (03) : 471 - 480
  • [43] Correlation of radiotherapy with the prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping
    Zhang, Jin
    CANCER RESEARCH, 2020, 80 (04)
  • [44] Correlation of radiotherapy with the prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping
    Zhang, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] Correlation of radiotherapy with prognosis of elderly patients with hormone receptor-positive breast cancer according to immunohistochemical subtyping
    Zhi, Xiangcheng
    Yang, Xiaonan
    Pan, Teng
    Liu, Jingjing
    Chen, Xiao
    Lou, Liping
    Shi, Zhendong
    Zhang, Jin
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (03) : 471 - 480
  • [46] Cochrane review of capecitabine for hormone receptor positive versus hormone receptor negative breast cancer
    Redfern, A.
    Lau, P.
    White, A.
    Hoon, S.
    Bulsara, M.
    Long, A.
    CANCER RESEARCH, 2017, 77
  • [47] Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer
    Hoon, Siao-Nge
    Lau, Peter K. H.
    White, Alison M.
    Bulsara, Max K.
    Banks, Patricia D.
    Redfern, Andrew D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (05):
  • [48] A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast Cancer
    Barroso-Sousa, Romualdo
    Krop, Ian E.
    Trippa, Lorenzo
    Tan-Wasielewski, Zhenying
    Li, Tianyu
    Osmani, Wafa
    Andrews, Chelsea
    Dillon, Deborah
    Richardson, Edward T., III
    Pastorello, Ricardo G.
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Bellon, Jennifer R.
    Schoenfeld, Jonathan D.
    Tolaney, Sara M.
    CLINICAL BREAST CANCER, 2020, 20 (03) : 238 - 245
  • [49] Efficacy and Safety of Radiotherapy Combined with Pyrotinib in the Treatment of HER2-Positive Breast Cancer with Brain Metastases
    Huang, Jie
    Zhu, Wenqiang
    Duan, Qiangzhi
    Zhu, Chaomang
    Shi, Xueling
    Zhao, Hongyu
    Cai, Peng
    Li, Duojie
    BREAST CANCER-TARGETS AND THERAPY, 2023, 15 : 841 - 853
  • [50] Molecular alterations associated with rapid progression following CDK4/6 inhibitors (CDKi) in metastatic hormone receptor-positive breast cancer (mHRBC).
    West, Malinda T.
    Goodyear, Shaun
    Kaempf, Andy
    Kartika, Thomas
    Ribkoff, Jessica
    Hobbs, Evthokia
    Mitri, Zahi Ibrahim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345